Protocol Ledger

NCT05008835 · Phase II · TERMINATED

Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

Interventional Phase II clinical trial protocol NCT05008835 sponsored by ACADIA Pharmaceuticals in Immunology, Rheumatology, and Dermatology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-07-20 Enrollment: 61 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05008835
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)61 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05008835
Protocol FieldVerified Registry Value
NCT IdentifierNCT05008835
Consolidated Lead SponsorACADIA Pharmaceuticals
Therapeutic Condition CohortImmunology, Rheumatology, and Dermatology
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment61 participants (ACTUAL)
Registered Start Date2021-07-20
WhyStopped ClassificationStrategic / Business / Sponsor Decision

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05008835
Hospital Research SiteLocationSite Profile
Encompass Clinical ResearchSpring Valley, CAOpen Hospital Dossier ->
Chase Medical Research, LLCWaterbury, CTOpen Hospital Dossier ->
Clinical Neuroscience Solutions, Inc.Jacksonville, FLOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI